Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Fibro/Adipogenic Progenitor Transplantation in a Model of Chemoradiation-induced Pathogenesis

FY 2023-24

Summary
The most recent data shows that 64% of children and 84% of adults diagnosed with cancer survive 5 or more years past diagnosis. Chemoradiation is the most common treatment for most cancers, including rhabdomyosarcoma that makes up about 3% of all tumours in children. Improved survival makes the long-term consequences of chemoradiation exposure a significant concern. Most cancer survivors experience significant muscle weakness, fatigue, and scarring after treatment due to chronic replacement of healthy muscle tissue with fatty, fibrous tissue. The negative consequences in muscle tissue currently have no cure. Previous data from our lab showed that chemoradiation therapy reduces the number of support cells that are essential for maintaining muscle growth. The support cells release signals that promote muscle growth and repair. Our lab found that after chemoradiation treatment, the function of these support cells are altered, the signals that they release are lost, and their levels are severely decreased. In this study, we will be subjecting mice with rhabdomyosarcoma tumours to chemoradiation treatment and then transplanting them with healthy support cells. The objective of this study is to determine if replacing these support cells in chemoradiated skeletal muscle can improve muscular growth and function. We expect to find that transplantation will restore muscle growth and reduce fatty, fibrous muscle content. These findings will have a significant impact on cancer survivors’ health through improvements in their long-term muscle quality and function. Our work will ultimately lead to long-term improvements in cancer survivors’ quality of life.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
505897
Name
Brabrook Cooper
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Fibro/Adipogenic Progenitor Transplantation in a Model of Chemoradiation-induced Pathogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cell Therapy; Chemotherapy; Fibro/Adipogenic Progenitors; Fibrosis; Health Care; Muscle Stem Cells; Muscular Atrophy; Muscular Regeneration; Radiotherapy
Abstract
The most recent data shows that 64% of children and 84% of adults diagnosed with cancer survive 5 or more years past diagnosis. Chemoradiation is the most common treatment for most cancers, including rhabdomyosarcoma that makes up about 3% of all tumours in children. Improved survival makes the long-term consequences of chemoradiation exposure a significant concern. Most cancer survivors experience significant muscle weakness, fatigue, and scarring after treatment due to chronic replacement of healthy muscle tissue with fatty, fibrous tissue. The negative consequences in muscle tissue currently have no cure. Previous data from our lab showed that chemoradiation therapy reduces the number of support cells that are essential for maintaining muscle growth. The support cells release signals that promote muscle growth and repair. Our lab found that after chemoradiation treatment, the function of these support cells are altered, the signals that they release are lost, and their levels are severely decreased. In this study, we will be subjecting mice with rhabdomyosarcoma tumours to chemoradiation treatment and then transplanting them with healthy support cells. The objective of this study is to determine if replacing these support cells in chemoradiated skeletal muscle can improve muscular growth and function. We expect to find that transplantation will restore muscle growth and reduce fatty, fibrous muscle content. These findings will have a significant impact on cancer survivors’ health through improvements in their long-term muscle quality and function. Our work will ultimately lead to long-term improvements in cancer survivors’ quality of life.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brabrook, Cooper
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~